[Antiviral effects of 9-beta-D-arabinofuranosyl-2,6-diaminopurine against experimental herpetic keratitis].
D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007635:Keratitis, Dendritic / Q000188:drug therapy*; D009824:Ointments; D011817:Rabbits; D013535:Suspensions; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000998:Antiviral Agents; D009824:Ointments; D013535:Suspensions; C011221:ara-DAP; D014740:Vidarabine